scholarly journals Former Hormonal Contraceptive User

2020 ◽  
Author(s):  
Keyword(s):  
Hormonal Contraceptive ◽  
Contraceptive User

scholarly journals Analisis Kenaikan Berat Badan Pada Akseptor KB Suntik DI BPM HJ. M

2019 ◽  
pp. 197-204
Author(s):  
Nurul Hidayah ◽  
Desi Lestia Dwisalmarini
Keyword(s):  
Weight Gain ◽  
Family Planning ◽  
Hormonal Contraception ◽  
Sampling Technique ◽  
Total Sample ◽  
Hormonal Contraceptive ◽  
Cross Sectional ◽  
Purposive Sampling ◽  
Contraceptive User ◽  
Injectable Contraceptive

Latar Belakang: Program Keluarga Berencana digunakan sebagai salah satu cara untuk menekan pertumbuhan jumlah penduduk. Banjarmasin adalah pengguna kontrasepsi suntik terbanyak. Studi pendahuluan yang saya dilakukan di BPM yaitu dari 10 akseptor kontrasepsi suntik 6 akseptor yang mengalami kenaikan berat badan yaitu 4 pengguna KB suntik 3 bulan dengan lama pemakaian 1,5 tahun dan 2 pengguna akseptor suntik 1 bulan dengan lama pemakaian 2 tahun.Tujuan: Menganalisis kenaikan berat badan pada akseptor KB suntik.Metode: Non eksperimental dengan pendekatan Cross Sectional. Populasi penelitian adalah akseptor kontrasepsi suntik yang menggunakan Cyclofem dan suntik DMPA (Depo Medroxyprogesterone Acetat) di BPM Hj. M dari bulan oktober sampai bulan Desember 2015 berjumlah 188 orang. Jumlah sampel  65 peserta KB Suntik. Teknik sampling menggunakan Purposive Sampling. Pengumpulan data menggunakan angket. Analisis dengan Uji T tidak Berpasangan (P=0,05).Hasil: Menganalisis kenaikan berat badan pada akseptor KB suntik yaitu rata-rata suntik 1 bulan 1,3 dan suntik 3 bulan 3,8 dengan nilai p 0,001 hasil penelitian ini menunjukan adanya perbedaan kenaikan berat badan suntik 1 bulan dan suntik 3 bulan.Simpulan: Ada perbedaan pengguna kontrasepsi hormonal suntikan dengan kenaikan berat badan.  Dalam penelitian ini dapat disimpulkan bahwa pengguna KB suntik 3 bulan lebih besar mengalami kenaikan berat badan dibandingkan suntik 1 bulan. Kata Kunci: Berat Badan, Kontrasepsi Hormonal SuntikanAbstract :Background: The Family Planning Program is used as a way to reduce population growth. Banjarmasin is the most injectable contraceptive user. The preliminary study I conducted at BPM was from 10 injectable contraceptive acceptors 6 acceptors who gained weight, namely 4 users of 3-month injection contraception with 1.5 years of usage duration and 2 users of 1-month injection acceptors with 2 years of usage duration.Objective: To analyze weight gain in injection KB acceptors.Method: Non experimental with Cross Sectional approach. The study population was injection contraceptive acceptors who used Cyclofem and injected DMPA (Medroxyprogesterone Acetat Depo) at BPM Hj. M from October to December 2015 amounted to 188 people. The total sample is 65 injecting family planning participants. The sampling technique uses Purposive Sampling. Data collection uses questionnaires. Analysis with the No Paired T Test (P = 0.05).Results: Analyzing the increase in body weight in injectable family planning acceptors, namely 1 month 1.3 injection and 3.8 months injection with 3.8 p values 0.001. The results of this study showed a difference in 1 month injection and 3 month injections.Conclusion: There are differences in injectable hormonal contraceptive users with weight gain. In this study it can be concluded that injecting family planning users 3 months bigger experience weight gain compared to 1 month injection.Keywords: Weight Loss, Hormonal Contraception Injections

ECTOPIC PREGNANCY WITH ACCEPTOR IMPLANT

2019 ◽  
Vol 3 (1) ◽  
pp. 48-55
Author(s):  
Putri Zelfitri Zen ◽  
Yusrawati Yusrawati
Keyword(s):  
Ectopic Pregnancy ◽  
Contraceptive Use ◽  
Abdominal Cavity ◽  
Uterine Cavity ◽  
Hormonal Contraceptive ◽  
Obstetrics And Gynecology

Objective: To report a case of Ectopic pregnancy with implant receptorsMaterials and Methods: This article describes the case of a 41-year-old woman, diagnosed with an Ectopic Pregnancy on the gravid G5P4A0H4 11-12 weeks. Patients are using implant contraception, which has been used since 2009-2018 (3 installations). The patient came to the obstetrics and gynecology clinic Dr. M. Djamil Padang. The ultrasound gives the impression of Ectopic pregnancy in the infindibule tube. Analysis Ectopic pregnancy can also occur due to the influence of hormonal contraceptive use (progesterone).Results: Patient gets intervention performed laparotomy After the peritoneum is opened it appears fresh red blood amounting to ± 500 cc filling the abdominal cavity. Blood evacuation and exploration are performed, it appears that the source of bleeding originates from the left tubal rupture (Infundibulum) Impression of the left tubal rupture (Infundibulum) ecectic ectopic pregnancy is impaired. Sinistal salpingectomy is performed.Conclusion: Ectopic pregnancy Ectopic pregnancy is all pregnancies where the ovum fertilized by spermatozoa implant and grows outside the uterine cavity endometrial.

scholarly journals Is the use of contraceptives associated with periodontal diseases? A systematic review and meta-analyses

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Micaele Maria Lopes Castro ◽  
Maria Karolina Martins Ferreira ◽  
Iasmin Encaua Essashika Prazeres ◽  
Paula Beatriz de Oliveira Nunes ◽  
Marcela Baraúna Magno ◽  
...  
Keyword(s):  
Systematic Review ◽  
Quantitative Analysis ◽  
Periodontal Diseases ◽  
Hormonal Contraceptive ◽  
Cochrane Library ◽  
Hormonal Contraceptives ◽  
Clinical Parameters ◽  
Significant Difference ◽  
Meta Analyses ◽  
The Impact

Abstract Background Previous studies indicated an impact of hormonal contraceptive use on oral health. This systematic review aimed to investigate the evidence supporting the impact of the use of hormonal contraceptives and periodontal diseases. Methods This study is based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and based on the PECO acrostic. Inclusion criteria comprised observational studies including women (P), which evaluated hormonal contraceptive users (E) and hormonal contraceptive non-users (C), to verify the association between this hormonal therapy and the periodontal diseases (O). Searches were performed on 5 databases: PubMed, Scopus, Web of Science, Cochrane Library, LILACS and grey literature (OpenGrey and Google Scholar). After the selection process, the included studies were evaluated qualitatively. Moreover, quantitative data were analyzed in two meta-analyses for clinical attachment loss (CAL) and probing depth (PD). Finally, the level of certainty was measured with the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) tool between periodontal clinical parameters. Results 18 articles were eligible for the qualitative synthesis and 7 of them were selected for quantitative analysis. Hence, 15 of the eligible articles reported an association between the use of hormonal contraceptives and severity of periodontal disease. However, 6 articles demonstrated high risk of bias and were excluded from quantitative synthesis. The meta-analysis showed a statistically significant difference for CAL (MD 0.24 [0.09, 0.40]; p = 0.002), but in PD (MD 0.05 [− 0.05, 0.15]; p = 0.33) such difference was not identified. A very low level of evidence was found between the clinical parameters. Conclusions The use of hormonal contraceptives may be associated to severity of periodontal diseases. However, the quantitative analysis points to an inconclusive outcome due to the high level of heterogeneity. The association is biologically plausible, however additional studies are warranted to better elucidate the clinical significance of this possible association.

scholarly journals Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study

2021 ◽  
Author(s):  
Gabriele S. Merki-Feld ◽  
Peter S. Sandor ◽  
Rossella E. Nappi ◽  
Heiko Pohl ◽  
Christoph Schankin
Keyword(s):  
Cohort Study ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Hormonal Contraception ◽  
Hormonal Contraceptive ◽  
Natural Cycle ◽  
Free Interval ◽  
Migraine Frequency ◽  
Combined Hormonal Contraception ◽  
Migraine Onset

AbstractMany studies have described the features of menstrually related migraines but there is a lack of knowledge regarding the features of migraine in combined hormonal contraceptive users (CHC). Hormone-withdrawal migraines in the pill-free period could differ from those in the natural cycle. Gynaecologic comorbidities, like dysmenorrhea and endometriosis, but also depression or a family history might modify the course of migraine. A better understanding of migraine features linked to special hormonal situations could improve treatment. For this prospective cohort study, we conducted telephone interviews with women using a CHC and reporting withdrawal migraine to collect information on migraine frequency, intensity, triggers, symptoms, pain medication, gynaecologic history and comorbidities (n = 48). A subset of women agreed to also document their migraines in prospective diaries. The mean number of migraine days per cycle was 4.2 (± 2.7). Around 50% of these migraines occurred during the hormone-free interval. Migraine frequency was significantly higher in women who suffered from migraine before CHC start (5.0 ± 3.1) (n = 22) in comparison to those with migraine onset after CHC start (3.5 ± 2.1) (n = 26). Menstrually related attacks were described as more painful (57.5%), especially in women with migraine onset before CHC use (72%) (p < 0.02). Comorbidities were rare, except dysmenorrhea. The majority of migraine attacks in CHC users occur during the hormone-free interval. Similar as in the natural cycle, hormone-withdrawal migraines in CHC users are very intense and the response to acute medication is less good, especially in those women, who developed migraine before CHC use.

The association between hormonal contraceptive use and glaucoma in women of reproductive age

2021 ◽  
Author(s):  
Kate Hogden ◽  
Frederick Mikelberg ◽  
Mohit Sodhi ◽  
Farzin Khosrow‐Khavar ◽  
Mohammad Ali Mansournia ◽  
...  
Keyword(s):  
Contraceptive Use ◽  
Hormonal Contraceptive ◽  
Reproductive Age ◽  
Women Of Reproductive Age

scholarly journals Influence of Menstrual Cycle or Hormonal Contraceptive Phase on Energy Intake and Metabolic Hormones—A Pilot Study

Endocrines ◽  
2021 ◽  
Vol 2 (2) ◽  
pp. 79-90
Author(s):  
Johanna K. Ihalainen ◽  
Ida Löfberg ◽  
Anna Kotkajuuri ◽  
Heikki Kyröläinen ◽  
Anthony C. Hackney ◽  
...  
Keyword(s):  
Menstrual Cycle ◽  
Energy Intake ◽  
Hormonal Contraceptive ◽  
Group Differences ◽  
Metabolic Hormones ◽  
Recreational Athletes ◽  
Total Ghrelin ◽  
17Β Estradiol ◽  
The Mean ◽  
And Training

Sex hormones are suggested to influence energy intake (EI) and metabolic hormones. This study investigated the influence of menstrual cycle (MC) and hormonal contraceptive (HC) cycle phases on EI, energy availability (EA), and metabolic hormones in recreational athletes (eumenorrheic, NHC = 15 and monophasic HC-users, CHC = 9). In addition, 72-h dietary and training logs were collected in addition to blood samples, which were analyzed for 17β-estradiol (E2), progesterone (P4), leptin, total ghrelin, insulin, and tri-iodothyronine (T3). Measurements were completed at four time-points (phases): Bleeding, mid-follicular (FP)/active 1, ovulation (OVU)/active 2, mid-luteal (LP)/inactive in NHC/CHC, respectively. As expected, E2 and P4 fluctuated significantly in NHC (p < 0.05) and remained stable in CHC. In NHC, leptin increased significantly between bleeding and ovulation (p = 0.030) as well as between FP and OVU (p = 0.022). No group differences in other measured hormones were observed across the MC and HC cycle. The mean EI and EA were similar between phases, with no significant differences observed in macronutrient intake over either the MC or HC. While the MC phase might have a small, but statistically significant effect on leptin, the findings of the present study suggest that the MC or HC phase does not significantly alter ad libitum EI or EA in recreational athletes.

scholarly journals Short-acting hormonal contraceptive continuation among low-income postpartum women in Texas

2020 ◽  
pp. 100052
Author(s):  
Kristen Lagasse Burke ◽  
Lauren Thaxton ◽  
Joseph E. Potter
Keyword(s):  
Low Income ◽  
Hormonal Contraceptive ◽  
Postpartum Women ◽  
Short Acting
Sign in / Sign up

Export Citation Format

Share Document